Evidence map›Paper›PMID 42677082›Full record

ReviewHealth science reports2026

Effects of Drug Resistance on the Global Spread of Malaria: A Systematic Literature Review.

Ashenafi Woldemichael Woime

Abstract readReview
In one paragraph

Review in Health science reports, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

1 author.

Ashenafi Woldemichael WoimeDepartment of Environmental Health Hossana College of Health Sciences Hossana Ethiopia.ORCID https://orcid.org/0009-0001-0643-0736

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background and Aims: Malaria remains a major health crisis in tropical regions, with Sub-Saharan Africa bearing the heaviest burden. While insecticide-treated nets and artemisinin-based combination therapies (ACTs) have reduced cases, emerging parasite resistance to artemisinin threatens these gains. This review synthesizes evidence on how drug resistance impacts malaria transmission and control globally. Methods: This systematic review followed PRISMA 2020 guidelines and was registered with PROSPERO (CRD420261336060). A comprehensive search of PubMed/MEDLINE, Embase, and Web of Science, supplemented by hand-searching and grey literature, identified studies published between January 2011 and December 2025. Of 897,299 initial records, 22 studies met the inclusion criteria after screening and quality assessment using JBI, the Newcastle-Ottawa Scale, and Cochrane RoB 2 tools. Data were summarized thematically; meta-analysis was not conducted due to heterogeneity and varying bias. Sensitivity analysis confirmed robustness. Results: Drug resistance reduces treatment effectiveness and increases transmission. Artemisinin resistance, primarily associated with Conclusion: Without urgent global collaboration, resistance will undermine malaria elimination and increase disease burden. This review calls attention to novel treatments, enhanced surveillance, and regionally tailored strategies to contain resistance and sustain malaria control efforts worldwide.

Indexed as

artemisinin‐based combination therapies (ACTs)drug resistanceKelch13 mutationsmalariamolecular surveillance

Identifiers

PMID42677082
PMCPMC13527588

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.